Technology News and Research

RSS

Arsanis closes Series A financing for $10 million

Arsanis, Inc, a recently founded biotechnology company dedicated to the development of anti-infective monoclonal antibody therapeutics, today announced the closing of a Series A financing with a total funding amount of $10 million. Proceeds from the initial financing will be used to advance several programs in the anti-microbial infectious disease area.

28 Feb 2011

U.S. food prices could rise up to 4%, USDA says

U.S. food prices will "rise as much as 4% this year, more than the 2% to 3% estimated last month, after a surge in prices for farm goods, the U.S. Department of Agriculture" forecast Thursday during the agency's outlook conference in Washington, Bloomberg/Los Angeles Times reports.

28 Feb 2011

Survey: 65% of patients in hospitals experience pain prevalence

Nearly two-thirds of the hospital in-patients who took part in a survey had experienced pain in the last 24 hours and 42% of those rated their pain as more than seven out of ten, where ten was the worst pain imaginable, according to the March issue of the Journal of Clinical Nursing.

28 Feb 2011

Scientific Learning introduces new series of Virtual Brain Seminars for students

In today's economy, traveling to see renowned educators and authors speak at national conferences and seminars is no longer an option for many K-12 educators. Beginning this month, however, educators will have the opportunity to hear from nationally recognized experts in education, technology and neuroscience with the launch of a new series of Virtual Brain Seminars presented by Scientific Learning, makers of the Fast ForWord and Reading Assistant family of products.

28 Feb 2011

Selcia completes drug discovery project with ExonHit Therapeutics using fragment screening technology

Selcia Ltd today announced the successful completion of a drug discovery project with ExonHit Therapeutics SA, using Selcia's fragment screening technology. Novel and weak affinity hits were identified from Selcia's Fragment Library, using their proprietary CEfrag technique.

28 Feb 2011

First patient treated in KUR-023 pilot clinical trial to assess safety and efficacy of product candidate

Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has treated the first patient in a pilot clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.

28 Feb 2011

QIAGEN, Epigenomics enter option agreement to commercialize colorectal cancer blood test

Epigenomics AG, the cancer molecular diagnostics company, and QIAGEN today announced that the companies have entered into an option agreement allowing QIAGEN to develop and, should QIAGEN exercise the option, commercialize a colorectal cancer blood test based on Epigenomics' proprietary biomarker mSEPT9 and certain DNA methylation analysis technologies.

From QIAGEN Manchester Limited 28 Feb 2011

Study: Radio-guided surgery effectively removes nodules in patients with lung cancer

Using tiny spheres of radioactive liquid to guide surgeons as they remove potentially cancerous material in the lungs is safe and more effective than other techniques, Italian researchers report at the European Multidisciplinary Conference in Thoracic Oncology (EMCTO), 24-26 February 2011, Lugano, Switzerland.

28 Feb 2011

Kiwis can go online to support St John for Christchurch ambulance service infrastructure work

Kiwis worldwide can go online to support St John, the ambulance service provider helping residents and communities in Christchurch after the recent earthquake which devastated much of the city.

28 Feb 2011

New findings disclose mechanisms that control Rb2/p130 gene expression in lung cancer cells

Despite innumerable studies on lung cancer, many aspects of the disease have yet to be understood, including the role played by the retinoblastoma-related protein Rb2/p130 in the evolution of the disease.

27 Feb 2011

NIH-funded study finds way to reduce transmission of malaria to humans

Spraying malaria-transmitting mosquitoes with a genetically modified fungus can kill the malaria parasite without harming the mosquito, potentially reducing malaria transmission to humans, according to a new study published in the journal Science. Funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, the study was led by Raymond J. St. Leger, Ph.D., of the University of Maryland, College Park.

25 Feb 2011

LodgeNet Interactive annual 2010 revenue decreases to $452.2 million

LodgeNet Interactive Corporation today reported annual 2010 revenue of $452.2 million compared to $484.5 million in 2009. Net loss attributable to common stockholders was $(17.4) million or $(0.71) per share (basic and diluted) for 2010 compared to $(13.3) million or $(0.59) per share (basic and diluted) for 2009.

25 Feb 2011

Eigen ei-Nav|Artemis system for prostate biopsy installed at Smilow Comprehensive Prostate Cancer Center

As a world leader in the advancement of the detection and treatment of prostate cancer, the Smilow Comprehensive Prostate Cancer Center at NYU Langone Medical Center is the first medical facility in the Northeast to install ei-Nav|Artemis™, an innovative image guidance and navigation system for prostate biopsy that is manufactured by Eigen.

25 Feb 2011

Viewpoints: WSJ on Medicare Advantage, Texas Gov. Perry on 'Fed inroads,' Med students' health policy ignorance

The White House has apparently decided that it won't enforce the unpopular parts of its health-care plan until after the 2012 election. The latest evidence is its decision not to slash Medicare Advantage, the program that Democrats hate because it lets seniors choose private insurance options. ... Would this be the same Medicare Advantage that candidate Barack Obama vowed to eliminate, saying in 2007 that "We shouldn't be rewarding the insurance industry for deceiving and defrauding our seniors"? (2/25).

25 Feb 2011

Medtronic acquires chitosan-dextran gel technology for use in functional endoscopic sinus surgery

Medtronic, Inc. today announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research & Innovation Pty Ltd. in Australia, Robinson Squidgel Ltd., and Otago Innovation Ltd. in New Zealand. Medtronic is acquiring this technology for potential use in developing future products for functional endoscopic sinus surgery (FESS).

25 Feb 2011

FDA approves variance for sale of KODAK Systems using KODAK Laser Projection Technology

The Food and Drug Administration (FDA) has approved a variance that allows for the sale of KODAK Laser Projector Systems using KODAK Laser Projection Technology to cinema exhibitors without the need for individual site or show operator variances. This is an important step forward in delivering brighter 2D and 3D images that provide higher dynamic range and a wider color gamut to theaters.

25 Feb 2011

IPG Photonics fourth quarter revenues increase 86% year-over-year to $101 million

IPG Photonics Corporation today reported financial results for the fourth quarter of fiscal 2010 ended December 31, 2010.

25 Feb 2011

NASA certifies Superfocus glasses for astronauts with presbyopia

Superfocus LLC, creators of Superfocus glasses (formerly known as TruFocals) the first adjustable-focus eyeglasses to treat presbyopia, announced today the flight certification of Superfocus by the National Aeronautics and Space Administration (NASA) for use by astronauts on Discovery's final spaceflight (STS-133) and aboard the International Space Station.

25 Feb 2011

First Super Glue, then dentist

In preparation for the Chicago Dental Society's 146th annual Midwinter Meeting, which will draw more than 30,000 dental professionals to Chicago this February, society members were asked about current trends, dental care tips and more. More than 300 of the society's member dentists responded to the fall 2010 survey.

25 Feb 2011

Enrollment commences in NORDIC implantable cardioverter defibrillator clinical trial

BIOTRONIK SE & Co. KG announced today the start of the NORDIC ICD clinical trial. The first implantable cardioverter defibrillator (ICD) patients were enrolled by its coordinating clinical investigator, Prof. Dr. Dietmar Bänsch at the University Hospital of Rostock and the investigator Dr. Stefan Kuster at the DRK Hospital of Mölln/Ratzeburg.

25 Feb 2011

Technology News and Research

Arsanis closes Series A financing for $10 million

U.S. food prices could rise up to 4%, USDA says

Survey: 65% of patients in hospitals experience pain prevalence

Scientific Learning introduces new series of Virtual Brain Seminars for students

Selcia completes drug discovery project with ExonHit Therapeutics using fragment screening technology

First patient treated in KUR-023 pilot clinical trial to assess safety and efficacy of product candidate

QIAGEN, Epigenomics enter option agreement to commercialize colorectal cancer blood test

Study: Radio-guided surgery effectively removes nodules in patients with lung cancer

Kiwis can go online to support St John for Christchurch ambulance service infrastructure work

New findings disclose mechanisms that control Rb2/p130 gene expression in lung cancer cells

NIH-funded study finds way to reduce transmission of malaria to humans

LodgeNet Interactive annual 2010 revenue decreases to $452.2 million

Eigen ei-Nav|Artemis system for prostate biopsy installed at Smilow Comprehensive Prostate Cancer Center

Viewpoints: WSJ on Medicare Advantage, Texas Gov. Perry on 'Fed inroads,' Med students' health policy ignorance

Medtronic acquires chitosan-dextran gel technology for use in functional endoscopic sinus surgery

FDA approves variance for sale of KODAK Systems using KODAK Laser Projection Technology

IPG Photonics fourth quarter revenues increase 86% year-over-year to $101 million

NASA certifies Superfocus glasses for astronauts with presbyopia

First Super Glue, then dentist

Enrollment commences in NORDIC implantable cardioverter defibrillator clinical trial

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News